11 months, 1 week ago

In India, all vaccine-related AEFI are routinely monitored and COVID is no exception, says health expert

All ‘Adverse Events Following Immunisation’ after COVID-19 vaccinations continue to be monitored, a senior Union Health Ministry official, who did not wish to be named, said on Thursday. According to a study titled ‘Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India’, published in February 2023, the majority of serious AEFIs assessed for the study were either coincidental or vaccine product-related. The study concluded that the deaths reported under serious AEFIs were found to have a relatively lower consistent causal relationship with COVID-19 vaccines than the recovered hospitalisations in India. According to global data on TTS available in the public domain, as on January 5, 2024, Canada had reported 89 cases of TTS, of which 56 cases were reported following vaccination with AstraZeneca’s Vaxzevria/Covishield COVID-19 vaccine, and 24 cases were reported following vaccination with Pfizer-BioNTech’s Comirnaty COVID-19 vaccine.

The Hindu

Discover Related